State Street’s Verrica Pharmaceuticals VRCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$48.7K Sell
9,182
-47,523
-84% -$252K ﹤0.01% 4103
2025
Q1
$251K Buy
56,705
+4,393
+8% +$19.4K ﹤0.01% 3772
2024
Q4
$366K Buy
52,312
+1,030
+2% +$7.21K ﹤0.01% 3706
2024
Q3
$744K Buy
51,282
+6,104
+14% +$88.5K ﹤0.01% 3528
2024
Q2
$3.29M Buy
45,178
+3,918
+9% +$286K ﹤0.01% 3100
2024
Q1
$2.44M Buy
41,260
+2,333
+6% +$138K ﹤0.01% 3215
2023
Q4
$2.85M Buy
38,927
+653
+2% +$47.8K ﹤0.01% 3187
2023
Q3
$1.49M Buy
38,274
+663
+2% +$25.8K ﹤0.01% 3430
2023
Q2
$2.17M Buy
37,611
+30,839
+455% +$1.78M ﹤0.01% 3377
2023
Q1
$440K Buy
6,772
+490
+8% +$31.8K ﹤0.01% 3782
2022
Q4
$173K Hold
6,282
﹤0.01% 4163
2022
Q3
$183K Sell
6,282
-2,000
-24% -$58.3K ﹤0.01% 4190
2022
Q2
$159K Sell
8,282
-14,822
-64% -$285K ﹤0.01% 4309
2022
Q1
$1.87M Buy
23,104
+462
+2% +$37.5K ﹤0.01% 3592
2021
Q4
$2.07M Sell
22,642
-123
-0.5% -$11.3K ﹤0.01% 3625
2021
Q3
$2.85M Buy
22,765
+1,330
+6% +$166K ﹤0.01% 3512
2021
Q2
$2.42M Sell
21,435
-400
-2% -$45.2K ﹤0.01% 3513
2021
Q1
$3.31M Sell
21,835
-483
-2% -$73.2K ﹤0.01% 3228
2020
Q4
$2.57M Sell
22,318
-940
-4% -$108K ﹤0.01% 3265
2020
Q3
$1.8M Sell
23,258
-392
-2% -$30.3K ﹤0.01% 3240
2020
Q2
$2.6M Buy
23,650
+170
+0.7% +$18.7K ﹤0.01% 3072
2020
Q1
$2.57M Buy
23,480
+1,028
+5% +$112K ﹤0.01% 2947
2019
Q4
$3.57M Buy
22,452
+1,609
+8% +$256K ﹤0.01% 3011
2019
Q3
$3.08M Buy
20,843
+2,710
+15% +$400K ﹤0.01% 3045
2019
Q2
$2.11M Buy
18,133
+9,645
+114% +$1.12M ﹤0.01% 3225
2019
Q1
$918K Buy
8,488
+244
+3% +$26.4K ﹤0.01% 3353
2018
Q4
$672K Buy
8,244
+3,284
+66% +$268K ﹤0.01% 3401
2018
Q3
$808K Buy
+4,960
New +$808K ﹤0.01% 3431